SCAI expert consensus statement for infrapopliteal arterial intervention appropriate use

Catheterization and Cardiovascular Interventions

Volumn 84, Issue 4, 2014, Pages 539-545

  Gray, Bruce H ^a   Diaz Sandoval, Larry J ^b   Dieter, Robert S ^c,f   Jaff, Michael R ^d   White, Christopher J ^e  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE GREENVILLE   (United States)

^b Metro Health Hospital   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

^d HARVARD UNIVERSITY   (United States)

^e JOHN OCHSNER HEART AND VASCULAR INSTITUTE   (United States)

^f Nephrology Section   (United States)

Author keywords

appropriate use; peripheral arterial disease; peripheral intervention

Indexed keywords

EVEROLIMUS; PACLITAXEL; RAPAMYCIN;

ANATOMICAL VARIATION; ANGIOPLASTY; ARTICLE; ATHERECTOMY; BALLOON; BARE METAL STENT; CLAUDICATION; CLINICAL DECISION MAKING; COMORBIDITY; CONSENSUS DEVELOPMENT; CRITICAL LIMB ISCHEMIA; CUTTING BALLOON ANGIOPLASTY; DISEASE CLASSIFICATION; DRUG COATED BALLOON; DRUG ELUTING STENT; ENDOVASCULAR SURGERY; EVIDENCE BASED MEDICINE; HUMAN; INFRAPOPLITEAL ARTERY DISEASE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PATIENT CARE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF EXPANDING NITINOL STENT; SURVIVAL TIME; VASCULAR ACCESS; ADVERSE EFFECTS; CONSENSUS; DEVICES; INTERVENTIONAL RADIOLOGY; PATHOPHYSIOLOGY; PATIENT SELECTION; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PRACTICE GUIDELINE; PREDICTIVE VALUE; RISK FACTOR; STANDARDS; STENOSIS, OCCLUSION AND OBSTRUCTION; STENT; TREATMENT OUTCOME; VASCULAR PATENCY;

CONSENSUS; CONSTRICTION, PATHOLOGIC; ENDOVASCULAR PROCEDURES; HUMANS; PATIENT SELECTION; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; PREDICTIVE VALUE OF TESTS; RADIOGRAPHY, INTERVENTIONAL; RISK FACTORS; STENTS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84923084644     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25395     Document Type: Article

References (32)

1. European Working Group on Critical Limb Ischaemia. Second European Consensus Document on chronic critical leg ischaemia. Eur J Vasc Surg 1992; 6 (Suppl A): 1-32.
2. Wolfe JH, Wyatt MG,. Critical and subcritical ischaemia. Eur J Vasc Endovasc Surg 1997; 13: 578-582.
3. Aboyans V, Desormais I, Lacroix P, Salazar J, Criqui MH, Laskar M,. The general prognosis of patients with peripheral arterial disease differs according to the disease localization. JACC 2010; 55: 898-903.
4. Graziani L, Silvestro A, Bertone V, Manara E, Andreini R, Sigala A, Mingardi R, De Giglio R,. Vascular involvement in diabetic subjects with ischemic foot ulcer: A new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg 2007; 33: 453-460.
5. Gray BH, Grant AA, Kalbaugh CA, Blackhurst D, Langan EM III, Taylor SA, Cull DL,. The impact of isolated tibial disease on outcomes in the critical limb ischemic population. Ann Vasc Surg 2010; 24: 349-359.
6. Sadek M, Ellozy SH, Turnbull IC, et al. Improved outcomes are associated with multilevel endovascular intervention involving the tibial vessels compared with isolated tibial intervention. J Vasc Surg 2009; 49: 638-644.
7. Bradbury AW, et al. Bypass versus angioplasty in severe ischemia of the leg (BASIL): Multicenter, randomized controlled trial. Lancet 2005; 366: 1925-1934.
8. Fernandez N, McEnaney R, Marone LK, et al. Predictors of failure and success of tibial interventions for critical limb ischemia. J Vasc Surg 2010; 52: 834-842.
9. Karnabatidis D, et al. Incidence, anatomical location, and clinical significance of compressions and fractures in infrapopliteal balloon-expandable metal stents. J Endovasc Ther 2009; 16: 15-22.
10. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, TASC II Working Group,. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45 (Suppl S): S5-S67.
11. Neville RF, Attinger CE, Bulan EJ, Ducic I, Thomassen M, Sidawy AN,. Revascularization of a specific angiosome for limb salvage: Does the target artery matter: Ann Vasc Surg 2009; 23: 367-373.
12. Iida O, Soga Y, Hirano K, Kawasaki D, Suzudi K, et al. Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions. J Vasc Surg 2012; 55: 363-370.
13. Alexndrescu V, Vincent G, Azdad K, et al. A reliable approach to diabetic neuroischemic foot wounds: Below-the-knee angiosome-oriented angioplasty. J Endovasc Ther 2011; 18: 376-387.
14. Bosiers M, Scheinert D, Peeters P, Torsello G, Zeller T, Deloose K, Schmidt A, Tessarek J, Vinck E, Schwartz LB,. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg 2012; 55: 390-398.
15. Rocha-Singh KJ, Jaff M, Joye J, Laird J, Ansel G, Schneider P,; on behalf of the VIVA Physicians. Major adverse limb events and wound healing following infrapopliteal artery stent implantation in patients with critical limb ischemia: The XCELL trial. Catheter Cardiovasc Interv 2012; 80: 1042-1051.
16. Romiti M, Albers M, Brochado-Neto FC, Durazzo AE, Pereira CA, DeLuccia N,. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 2008; 47: 975-981.
17. Jaffery Z, Grant AG, White CJ,. Critical limb ischemia: does long-term patency matter? Vasc Med 2010; 15: 439-441.
18. Ihnat DM, Mills JL,. Current assessment of endovascular therapy for infrainguinal arterial occlusive disease in patients with diabetes. J Vasc Surg. 2010; 52: 92S-95S.
19. Taylor SM, York JW, Cull DL, Kalbaugh CA, Cass AL, Langan EL III, Clinical success using patient-oriented outcome measures after lower extremity bypass and endovascular intervention for ischemic tissue loss. J Vasc Surg 2009; 50: 534-541.
20. Das TS, McNamara T, Gray BH, Sedillo GJ, Turley BR, Kollmeyer K, Rogoff M, Aruny JE,. Primary Cryoplasty therapy provides durable support limb salvage in critical limb ischemia patients with infrapopliteal lesions: 12-month follow-up results from the BTK Chill Trial. J Endovasc Ther 2009; 16: II19-II30.
21. Ansel GM, Sample NS, Botti III CF, Jr, Tracy AJ, Silver MJ, Marshall BJ, George BS,. Cutting balloon angioplasty of the popliteal and infrapopliteal vessels for symptomatic limb ischemia. Catheter and Cardiovasc Interv 2004; 61: 1-4.
22. Schmidt A, Piorkowski M, Werner M, et al. First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol 2011; 58: 1105-1109.
23. Zeller T, Sixt S, Schwarzwalder U, Schwarz T, Frank U, Burgelin K, Pochert V, Muller C, Noory E, Krankenberg H, Hauswald K, Neumann FJ, Rastan A,. Two-year results after directional Atherectomy of infrapopliteal arteries with the SilverHawk device. J Endovasc Ther 2007; 14: 232-240.
24. Laird JR, Zeller T, Gray BH, Scheinert D, Vranic M, Reiser C, Biamino G,; LACI Investigators. Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial. J Endovasc Ther 2006; 13: 1-11.
25. Kickuth R, Keo HH, Triller J, et al. Initial clinical experience with the 4-F self-expanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia. J Vasc Interv Radiol 2007; 18: 703-708.
26. Feiring AJ, Wesolowski AA, Lade S,. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: Early and one-year outcomes. J Am Coll Cardio 2004; 44: 2307-2314.
27. Siablis D, Karnabatidis D, Katsanos K, Diamantopoulos A, Spiliopoulos S, Kagadis GC, Tsolakis J,. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: Analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol 2009; 20: 1141-1150.
28. Rastan A, Tepe G, Krankenberg H, Zahorsky R, Beschorner U, Noory E, Sixt S, Schwarz T, Brechtel K, Böhme C, Neumann FJ, Zeller T,. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: A double-blind, multi-centre, randomized clinical trial. Eur Heart J 2011; 32: 2274-2281.
29. Karnabatidis D, Spiliopoulos S, Diamantopoulos A, Katsanos K, Kagadis GC, Kakkos S, Siablis D,. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia. J Endovasc Ther 2011; 18: 1-12.
30. Biondi-Zoccai GG, Sangiorgi G, Lotrionte M, Feiring A, Commeau P, Fusaro M, Agostoni P, Bosiers M, Peregrin J, Rosales O, Cotroneo AR, Rand T, Sheiban I,. Infragenicular stent implantation for below-the-knee atherosclerotic disease: Clinical evidence from an international collaborative meta-analysis on 640 patients. J Endovasc Ther 2009; 16: 251-260.
31. Scheinert D, Katsanos K, Zeller T, Koppensteiner R, et al. A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the Sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES Trial. J Am Coll Cardiol 2012; 60: 2290-2295.
32. Bosiers M, Peeters P, D'Archambeau O, Hendriks J, Pilger E, Düber C, Zeller T, Gussmann A, Lohle PN, Minar E, Scheinert D, Hausegger K, Schulte KL, Verbist J, Deloose K, Lammer J,; AMS INSIGHT Investigators. AMS INSIGHT-Absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis. Cardiovasc Intervent Radiol 2009; 32: 424-435.